Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DLBS1033 Therapy in Improving Hypercoagulation State in Subjects With Type 2 Diabetes Mellitus

NCT01865474 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT01865474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01865474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DLBS1033 Therapy in Improving Hypercoagulation State in Subjects With Type 2 Diabetes Mellitus
Lead sponsor
Dexa Medica Group
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2013
Completion date
June 30, 2016
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus